• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Erratum: Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum].勘误：一线内分泌治疗对激素敏感性晚期乳腺癌患者的影响：一项网状Meta分析[勘误]
Onco Targets Ther. 2018 Jul 31;11:4449. doi: 10.2147/OTT.S179985. eCollection 2018.
2
Corrigendum.勘误
Paediatr Child Health. 2015 Nov-Dec;20(8):466-7. doi: 10.1093/pch/20.8.466.
3
ERRATUM.勘误
Int J Bioprint. 2020 Sep 17;6(4):309. doi: 10.18063/ijb.v6i4.309. eCollection 2020.
4
Erratum: Corrigendum: Survival and treatment patterns in elderly patients with advanced non-small-cell lung cancer in Manitoba.勘误：更正：曼尼托巴省老年晚期非小细胞肺癌患者的生存及治疗模式。
Curr Oncol. 2012 Feb;19(1):e42. doi: 10.3747/co.19.1012.
5
Erratum: Profile of buparlisib and its potential in the treatment of breast cancer: evidence to date [Corrigendum].勘误：布帕利昔的概况及其在乳腺癌治疗中的潜力：迄今的证据[勘误]
Breast Cancer (Dove Med Press). 2018 Mar 16;10:51. doi: 10.2147/BCTT.S166117. eCollection 2018.
6
Erratum: Eribulin for the treatment of metastatic breast cancer: an update on its safety and efficacy [Corrigendum].勘误：艾日布林治疗转移性乳腺癌：安全性和疗效最新进展[勘误]
Int J Womens Health. 2015 Apr 16;7:403. doi: 10.2147/IJWH.S85889. eCollection 2015.
7
Erratum: Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature [Corrigendum].勘误：原发性神经内分泌乳腺癌：一项回顾性分析及文献综述 [勘误]
Onco Targets Ther. 2017 Mar 21;10:1707. doi: 10.2147/OTT.S135552. eCollection 2017.
8
Erratum: Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum].勘误：肿瘤坏死因子-308多态性与非霍奇金淋巴瘤的风险及预后：一项荟萃分析研究[勘误]
Onco Targets Ther. 2016 May 27;9:3135. doi: 10.2147/OTT.S111427. eCollection 2016.
9
Erratum: Corrigendum: Progression-free survival in advanced ovarian cancer: a Canadian review and expert panel perspective.勘误：高级卵巢癌的无进展生存期：加拿大的回顾和专家小组观点。
Curr Oncol. 2011 Dec;18(6):303.
10
Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis.一线内分泌治疗对激素敏感性晚期乳腺癌患者的疗效：一项网状Meta分析
Onco Targets Ther. 2018 May 8;11:2647-2656. doi: 10.2147/OTT.S165681. eCollection 2018.

勘误：一线内分泌治疗对激素敏感性晚期乳腺癌患者的影响：一项网状Meta分析[勘误]

Erratum: Effect of first-line endocrine therapy in patients with hormone-sensitive advanced breast cancer: a network meta-analysis [Corrigendum].

出版信息

Onco Targets Ther. 2018 Jul 31;11:4449. doi: 10.2147/OTT.S179985. eCollection 2018.

DOI:10.2147/OTT.S179985
PMID:30104886
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6074807/
Abstract

[This corrects the article on p. 2647 in vol. 11, PMID: 29780257.].

摘要

[这更正了第11卷第2647页上的文章， PMID: 29780257。]